1. [1] ICH Expert Working Group, ICH Harmonized Tripartite Guideline, Pharmaceutical Development Q8, Revision 2, 2009.
2. [2] U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry, PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, 2004.
3. [3] T. Mizuta, Seizo Risk to PAT Guidance oyobi PAT no Syuho, PDA J. GMP Val. Japan 7 (2005) 25–37.
4. [4] M. Fujiwara, W. Momose, K. Kuroda, T. Inatani, K. Yamashita, K. Sako, Proportional control of moisture content of granules by adjusting inlet air temperature in fluidized bed granulation using near-infrared spectroscopy, Adv. Powder Technol. 25 (2014) 704–709.
5. [5] H. Nakagawa, Y. Kikkawa, K. Matsuura, S. Tanabe, T. Watanabe, Implementation of enhanced QbD to drug product development, J. Japan Soc. Pharm. Mach. Eng. 24 (2015) 469–475.